Procurement Summary
Country : USA
Summary : Chemistry Analyzer and Reagents Keesler AFB
Deadline : 27 May 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 119479519
Document Ref. No. : HT940825R0008
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Synopsis - Chemistry Lab Keesler Air Force Base
The Defense Health Agency Contracting Activity, Healthcare Contracting Division - South (HCD-S), San Antonio, Texas intends to issue a solicitation for Chemistry Analyzers and Reagents for the Keesler Medical Center at Keesler Air Force Base, Biloxi, MS. The Keesler Medical Center requires chemistry analyzers, immunoassay analyzers and automated specimen track system including any necessary maintenance services, supplies and reagents needed to perform automated specimen processing to the Department of Clinical Laboratory and Pathology Services, Keesler Air Force Base Medical Center, Keesler Air Force Base Mississippi. All analyzers, automated specimen track system and bidirectional vendor supplied computer interface must have ability to connect to and be fully interoperable with Cerner Military Health System (MHS) Genesis Lab Information System. Training for all equipment, software and accessories will be provided by the vendor at no additional charge to the government. This requirement will be met via equipment rental/lease or on a Cost Per Reportable Result (CPRR) basis. Analyzers must be in place and fully operational i.e. ready for patient testing to include MHS Genesis build and validation and be approved by the Laboratory Director to begin patient testing by the start of the base year period of performance. All equipment and reagents shall be supplied and serviced through the Contractor to include all parts, equipment, supplies, and other services required to ensure Keesler Medical Center is able to meet its objectives as listed herein.
The anticipated period of performance for this requirement is five (5) years (12-month base period with four 12-month option periods).
This requirement is being solicited as Unrestricted through Full and Open Competition, resulting in one (1) Firm Fixed Price (FFP) award being made as a result of Lowest Price Technically Acceptable (LPTA). FAR part 12 a...
Active Contract Opportunity
Notice ID : HT940825R0008
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE HEALTH AGENCY (DHA)
Office: DEFENSE HEALTH AGENCY
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: May 20, 2025 02:58 pm CDT
Original Response Date: May 27, 2025 01:00 pm CDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jun 11, 2025
Initiative:
Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: Biloxi, MS USA
Documents
Tender Notice
SOO-Chemistry-2025.pdf